Medical Device Innovation — Is “Better” Good Enough?
2011; Massachusetts Medical Society; Volume: 365; Issue: 16 Linguagem: Inglês
10.1056/nejmp1109285
ISSN1533-4406
AutoresLisa G. Suter, A. David Paltiel, Benjamin N. Rome, Daniel Solomon, Ilya Golovaty, Hanna Gerlovin, Jeffrey N. Katz, Elena Losina,
Tópico(s)Osteoarthritis Treatment and Mechanisms
ResumoThe FDA approves many devices on the basis of similarity to precursors, possibly encouraging development of slightly improved, higher-cost devices. A modeling approach can illuminate interplay among efficacy and durability, patient characteristics, costs, and outcomes.
Referência(s)